INS and diabetes mellitus: Therefore, it is interesting to investigate whether Cdr1as, as a powerful miR-7 inhibitor/sponge, could improve the adaptation of islet cells for insulin secretion and could ultimately serve as a potential treatment target for obese diabetes.